Pulsenmore Ltd. (TLV:PULS)

Market Cap	186.37M
Revenue (ttm)	9.66M
Net Income (ttm)	-36.74M
Shares Out	50.59M
EPS (ttm)	-0.72
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	96,317
Average Volume	123,740
Open	378.30
Previous Close	378.30
Day's Range	361.00 - 389.40
52-Week Range	184.00 - 792.70
Beta	0.41
RSI	69.20
Earnings Date	Aug 14, 2025

About Verve Therapeutics

Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening. The company’s Pulsenmore home ultrasound system includes self-scan device, a handheld ultrasound cradle dock with the patient’s smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 58
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: PULS

Financial Performance

In 2024, Pulsenmore's revenue was 9.66 million, an increase of 56.12% compared to the previous year's 6.19 million. Losses were -36.74 million, -37.28% less than in 2023.